Understand the source comparison
Glow Stack Collagen: Protocol Comparison
Standard Hydrolysed Collagen 5–10 kDa average None None or incidental Minimal measurable change in dermal elasticity; plasma hydroxyproline increase of 8–15% Inefficient. Most peptides degraded before absorption; lacks cofactors for collagen cross-linking Type
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Standard Hydrolysed Collagen
- 5–10 kDa average
- None
- None or incidental
- Minimal measurable change in dermal elasticity; plasma hydroxyproline increase of 8–15%
- Inefficient. Most peptides degraded before absorption; lacks cofactors for collagen cross-linking
- Type I/III Blend (Low MW)
- ≤3 kDa, 60%+ under 2 kDa
- 500mg ascorbic acid co-dosed
- 5–7% improvement in skin elasticity (Journal of Cosmetic Dermatology, 2023); 10–12% reduction in fine lines
- Effective for collagen synthesis but limited dermal remodelling without copper cofactor
- Full Glow Stack (Optimised)
- ≤2 kDa dipeptides/tripeptides
- 1–3mg GHK-Cu (evening dose)
- 500mg ascorbic acid (morning, with peptides)
- 7.2% elasticity improvement, 13% wrinkle depth reduction (Nutrients, 2023); increased fibroblast density on biopsy
- Maximises both synthesis and cross-linking; sequenced dosing prevents oxidative degradation
- Topical-Only Protocols
- N/A (topical peptides 1–5 kDa)
- 2% GHK-Cu serum
- Topical ascorbic acid 10–20%
- Localised improvement in photoaged areas; limited systemic collagen markers
- Effective for targeted treatment but does not address systemic collagen loss; absorption limited to 1–2mm depth